Closed-Loop CSF Circuit for Targeted Drug Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods struggle to ensure accurate delivery of therapeutic doses to specific anatomical targets in the brain and control drug concentration in cerebrospinal fluid (CSF) in real time.

Innovation Solution

A closed-loop CSF circuit is formed with a therapeutic inlet and a pump to control CSF flow rates differently from natural rates, allowing for precise delivery and localization of therapeutic materials within the CSF circuit, which can include flow sensors, pressure sensors, and controllers to manage the flow and concentration of drugs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If intrathecal drug delivery is performed using conventional methods, then drug can be administered to the CNS, but it is difficult to ensure accurate delivery to specific anatomical targets and control real-time drug concentration

Engineering Contradiction:
Improvedelivery accuracy to target anatomyVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system incorporates sensors to detect drug concentration and flow rate in real-time, providing feedback to a control system that adjusts pump operation and drug delivery rates accordingly. This closed-loop feedback mechanism enables precise delivery to target anatomy while maintaining appropriate drug concentrations without requiring overly complex manual control systems

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system dynamically adjusts pump rates, flow rates, and drug delivery parameters based on real-time sensor feedback and predetermined treatment protocols. This dynamic control allows the system to adapt to individual patient needs and anatomical variations, improving delivery accuracy without requiring a completely complex static system design

Inventive Principle:
Principle #15Dynamics

2Speed

If CSF flow rate is increased to improve drug delivery speed, then therapeutic material reaches target faster, but drug concentration in CSF decreases

Engineering Contradiction:
Improvedrug delivery speedVSAvoiddrug concentration in CSF
Core Design Contradiction:
SpeedVSQuantity of substance

Solution Approach 1:

The system employs periodic pulsing of the pump to deliver drug in controlled bursts rather than continuous flow. This periodic action allows the pump to operate at high speeds during pulsing phases for rapid delivery, then pause during diastolic phases to allow drug concentration to build up in the CSF, achieving both fast delivery and adequate concentration

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The system changes multiple parameters simultaneously including pump rate, flow rate, and drug delivery rate in a coordinated manner. By adjusting these parameters together rather than independently, the system can maintain high delivery speed while preserving adequate drug concentration through optimized parameter combinations

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If larger volumes of CSF are used to ensure sufficient drug delivery, then therapeutic material can reach target, but toxicity increases

Engineering Contradiction:
Improvetherapeutic material deliveryVSAvoidtoxicity
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The system focuses drug delivery on specific target anatomy rather than distributing it throughout the entire CSF space. By localizing the therapeutic effect to the precise anatomical region needing treatment, the system achieves sufficient drug delivery to the target while minimizing overall drug volume and associated toxicity

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

Real-time sensor feedback monitors drug concentration and delivery effectiveness, allowing the control system to optimize the exact amount of drug needed for therapeutic effect. This feedback mechanism prevents excessive drug volumes from causing toxicity while ensuring sufficient delivery to the target, adjusting the quantity dynamically based on actual delivery performance

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS20250295852A1Subarachnoid fluid management method and system
Publication Date: 2025.09.25 ENCLEAR THERAPIES INC
  • US20250295852A1 patent drawing
  • US20250295852A1 patent drawing
  • US20250295852A1 patent drawing

AI summary

A CSF management method for use with a patient forms a closed loop CSF circuit between two points on the patient's body. The CSF circuit has a therapeutic inlet to receive a therapeutic material (e.g., a drug), and a pump having a pump outlet to direct CSF along the CSF circuit. The method controls the pump to direct CSF from the pump outlet at a CSF rate that is different from the natural flow rate (i.e., the natural CSF flow rate). The therapeutic material is added to the CSF via the therapeutic input at a therapeutic rate. The CSF rate is different than the therapeutic rate and/or may be greater than the therapeutic rate. Alternative methods may control a bolus drug infusion to localize the application to a target region.